Digital Health Strategies, Inc. (DHS), a healthcare-focused data and technology solutions company, has successfully closed a Series A funding round to support the expansion of its Share of Health™ patient loyalty platform. Led by prominent investors in the healthcare industry, the strategic investment aims to strengthen DHS’s data and technology solutions, enhancing its ability to help clients build patient loyalty, improve care coordination, and address care gaps.
Founded in 2014, DHS has experienced consistent growth and recently earned a place on the Inc. 5000 list of the fastest-growing private companies in America. The company serves major health systems, including Geisinger, Hackensack Meridian Health, and Providence Health.
Key investors in the Series A funding round include:
- David Schultz: Founder & CEO of MediaLogic, a strategic marketing firm specializing in healthcare, financial services, and technology. Mr. Schultz, the lead investor, will join the DHS Board of Directors.
- Michael H. Focht, Sr.: Former President, Executive Vice Chairman, and Board Member of Tenet Healthcare.
- T. Dennis Jorgensen: Former Senior Vice President and Chief Ethics Officer of Tenet Healthcare.
- Bob Dresing: Former Chairman of CareMetx, Founder of TheraCom, and Former CEO of the Cystic Fibrosis Foundation.
- Mark Hansan: Executive Chairman of CareMetx, Co-Founder of TheraCom, and Former COO of the Cystic Fibrosis Foundation.
- Craig Goodman: Healthcare consultant and investor, former Partner and COO of Lifematters.
- Barry Schochet: Operating Partner at CIC Partners and former Vice Chairman of Tenet Healthcare.
The funding will enable DHS to accelerate its growth trajectory and enhance its capabilities in patient-centric solutions. The company emphasizes the importance of patient loyalty in an evolving healthcare landscape, where health systems play a more significant role in the continuum of care. DHS aims to leverage its expertise to connect patients with needed care and services while optimizing its platform to convert satisfied patients into donors.
Ben Texter, co-founder and co-CEO of DHS, highlighted the critical role of patient loyalty and expressed confidence that the investment would enable the company to deepen its impact on patients and health systems.
John Simpson, co-founder and co-CEO of DHS, emphasized the significance of data at the core of their approach, leveraging proprietary propensity modeling to deliver personalized communications and foster long-term relationships between health systems and patients.
The DHS data team, led by Paul Matsui, former Executive Director of Optum/The Advisory Board Company’s Data and Analytics Group, plays a pivotal role in developing scalable and customized modeling services integrated into a comprehensive suite of precision marketing and fundraising solutions.
The Series A funding is expected to further DHS’s mission to empower health systems with advanced data and technology solutions for improved patient engagement and loyalty.